These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26703116)

  • 1. Contralateral breast cancer: incidence according to ductal or lobular phenotype of the primary.
    Langlands F; White J; Kearins O; Cheung S; Burns R; Horgan K; Sharma N; Dodwell D
    Clin Radiol; 2016 Feb; 71(2):159-63. PubMed ID: 26703116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.
    Vo TN; Meric-Bernstam F; Yi M; Buchholz TA; Ames FC; Kuerer HM; Bedrosian I; Hunt KK
    Am J Surg; 2006 Oct; 192(4):552-5. PubMed ID: 16978974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Pathologic Finding of Combined Lobular Carcinoma
    Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P
    Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology.
    Moran MS; Yang Q; Haffty BG
    Breast J; 2009; 15(6):571-8. PubMed ID: 19995377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
    Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
    BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival.
    García-Fernández A; Lain JM; Chabrera C; García Font M; Fraile M; Barco I; Torras M; Reñe A; González S; González C; Piqueras M; Veloso E; Cirera L; Pessarrodona A; Giménez N
    Breast J; 2015; 21(5):533-7. PubMed ID: 26190560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with invasive lobular breast cancer are less likely to undergo breast-conserving surgery: a population based study in the Netherlands.
    Truin W; Roumen RM; Siesling S; van der Heiden-van der Loo M; Duijm LE; Tjan-Heijnen VC; Voogd AC
    Ann Surg Oncol; 2015 May; 22(5):1471-8. PubMed ID: 25323475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004.
    Eheman CR; Shaw KM; Ryerson AB; Miller JW; Ajani UA; White MC
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1763-9. PubMed ID: 19454615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
    Sinha PS; Bendall S; Bates T
    Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
    Hogan MP; Goldman DA; Dashevsky B; Riedl CC; Gönen M; Osborne JR; Jochelson M; Hudis C; Morrow M; Ulaner GA
    J Nucl Med; 2015 Nov; 56(11):1674-80. PubMed ID: 26294295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there an association between invasive lobular carcinoma of the breast and a family history of gastric cancer?
    Chikman B; Davidson T; Kais H; Jeroukhimov I; Leshno A; Sandbank J; Halevy A; Lavy R
    Fam Cancer; 2016 Jan; 15(1):41-7. PubMed ID: 26358115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period.
    Fortunato L; Mascaro A; Poccia I; Andrich R; Amini M; Costarelli L; Cortese G; Farina M; Vitelli C
    Ann Surg Oncol; 2012 Apr; 19(4):1107-14. PubMed ID: 21913022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma.
    Shah C; Wilkinson JB; Shaitelman S; Grills I; Wallace M; Mitchell C; Vicini F
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e547-51. PubMed ID: 21640491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preoperative MRT of the breast in invasive lobular carcinoma in comparison with invasive ductal carcinoma].
    Diekmann F; Diekmann S; Beljavskaja M; Bick U; Taupitz M; Blohmer JU; Winzer KJ; Hamm B
    Rofo; 2004 Apr; 176(4):544-9. PubMed ID: 15088179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
    Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
    Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and treatment outcomes of invasive ductal and lobular carcinoma: analyses of 54,832 taiwan cancer registry index cases.
    Chen BF; Tsai YF; Lien PJ; Lin YS; Feng CJ; Chen YJ; Cheng HF; Tseng LM; Huang CC
    Breast Cancer Res Treat; 2023 Oct; 201(3):547-560. PubMed ID: 37470893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland.
    Verkooijen HM; Fioretta G; Vlastos G; Morabia A; Schubert H; Sappino AP; Pelte MF; Schäfer P; Kurtz J; Bouchardy C
    Int J Cancer; 2003 May; 104(6):778-81. PubMed ID: 12640687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival analysis between patients with invasive ductal and invasive lobular breast cancer.
    Dian D; Herold H; Mylonas I; Scholz C; Janni W; Sommer H; Friese K
    Arch Gynecol Obstet; 2009 Jan; 279(1):23-8. PubMed ID: 18449551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Treatment Outcome Between Invasive Lobular and Ductal Carcinomas in Patients Receiving Partial Breast Irradiation With Intraoperative Electrons.
    Leonardi MC; Maisonneuve P; Mastropasqua MG; Cattani F; Fanetti G; Morra A; Lazzari R; Bazzani F; Caputo M; Rotmensz N; Gerardi MA; Ricotti R; Enrica Galimberti V; Veronesi P; Dicuonzo S; Viale G; Jereczek-Fossa BA; Orecchia R
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):173-181. PubMed ID: 28816144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan.
    Kuo WH; Yen AM; Lee PH; Hou MF; Chen SC; Chen KM; Chen TH; Chang KJ
    Breast Cancer Res Treat; 2006 Sep; 99(2):221-8. PubMed ID: 16544057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.